Evaluation and management of dyspnea as the dominant presenting feature in neuromuscular disorders

2024-9-12

Hypogammaglobulinemia and infection risk in myotonic dystrophy type 1

2024-9-12

Assessing hepatitis B virus serologies when transitioning patients from intravenous immune globulin therapy to rituximab for the treatment of autoimmune neuromuscular diseases

2024-9-12

Multifocal motor neuropathy in Japan: A nationwide survey on prevalence, clinical profiles, and treatment

2024-9-10

Magnetic resonance neurography in the diagnosis of neurological subtypes of thoracic outlet syndrome

2024-9-10

Ultrasound assisted versus landmark based intrathecal administration of nusinersen in adults with spinal muscular atrophy disease: <scp>A</scp> randomized trial

2024-9-8

Initiation of noninvasive ventilation in patients with amyotrophic lateral sclerosis

2024-9-7

Predictors of mortality post‐gastrostomy in motor neuron disease patients

2024-9-6

“Chronic inflammatory demyelinating polyradiculoneuropathy” without demyelination on electrodiagnosis: When should a treatment trial be considered?

2024-9-6

Secondary outcomes of scoliosis surgery in disease‐modifying treatment‐naïve patients with spinal muscular atrophy type 2 and nonambulant type 3

2024-9-4

Amyotrophic Lateral Sclerosis and swim training affect copper metabolism in skeletal muscle in a mouse model of disease

2024-9-3

Re‐visiting the electrodiagnosis of <scp>Guillain‐Barré</scp> syndrome

2024-9-2

Skeletal muscle symptoms and quantitative <scp>MRI</scp> in females with dystrophinopathy

2024-9-2

The burden and preparedness of care partners of people living with amyotrophic lateral sclerosis at home in Korea

2024-8-29

Phrenic neuropathy etiologies and recovery trajectories in outpatient rehabilitation and neuromuscular medicine clinics: A retrospective analysis

2024-8-29

The difference in nerve ultrasound and motor nerve conduction studies between autoimmune nodopathy and chronic inflammatory demyelinating polyneuropathy

2024-8-28

Role of prazosin in patients with Guillain–Barré syndrome with sympathetic overactivity: A cohort study

2024-8-22

AANEM News &amp; Insights

2024-8-14

AANEM 2024 Annual Meeting Abstracts Guide

2024-8-14

Calendar of Events

2024-8-14

Issue Information

2024-8-14

Join AANEM

2024-8-14

Tissue <scp>Doppler</scp> ultrasound of arm muscles to assess myotonia in myotonic dystrophies: An exploratory study

2024-8-13

Outcome measures used in peripheral nerve surgery for symptomatic neuroma in upper extremity amputations: A scoping review

2024-8-13

Safety of risdiplam in spinal muscular atrophy patients after short‐term treatment with nusinersen

2024-8-13

Utility of the Clustering Index method for diagnosing neuromuscular disorders as compared with needle <scp>electromyography</scp>

2024-8-12

Usefulness of somatosensory evoked potentials for monitoring the clinical course of patients with chronic inflammatory demyelinating polyradiculoneuropathy

2024-8-12

Peripheral nerve injuries in the performing artist

2024-8-11

Nutrition outcomes of disease modifying therapies in spinal muscular atrophy: A systematic review

2024-8-11

Mitochondrial genome variants associated with amyotrophic lateral sclerosis and their haplogroup distribution

2024-8-9

Visualization and characterization of complement activation in acetylcholine receptor antibody seropositive myasthenia gravis

2024-8-8

Single simple question in axonal polyneuropathy

2024-8-8

Approach to gait disorders and orthotic management in adult onset neuromuscular diseases

2024-8-6

Six‐minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen

2024-8-2

Onasemnogene abeparvovec gene therapy for spinal muscular atrophy: A cohort study from the <scp>United Arab Emirates</scp>

2024-8-1

Characteristics of after‐discharges following compound muscle action potential or <scp>F</scp>‐wave in primary peripheral nerve hyperexcitability syndrome

2024-7-31

Utility of laryngeal electromyography for establishing prognosis and individualized treatment after laryngeal neuropathies

2024-7-30

Possible sex and racial disparities in myasthenia gravis care

2024-7-29

Homecare amyotrophic lateral sclerosis (ALS): A multidisciplinary, home‐based model of care for patients with ALS and their caregivers

2024-7-29

Myasthenia gravis Lambert–Eaton overlap syndrome: Recommended modification for the diagnostic criteria

2024-7-28

Dominant stop‐loss <i>HNRNPA1</i> variants in juvenile‐onset myopathy

2024-7-28

Ultrasonographic abnormalities in clinically unaffected nerves of patients with nonvasculitic motor and sensorimotor mononeuropathies

2024-7-26

Differences in corneal nerve fiber density and fiber length in patients with painful chronic idiopathic axonal polyneuropathy and diabetic polyneuropathy

2024-7-26

No sex‐based differences in odds of starting or time to treatment of generalized myasthenia gravis: A single center cohort study

2024-7-26

Transverse interlaminar ultrasound‐guided C1‐C2 puncture for the intrathecal administration of nusinersen in patients with spinal muscular atrophy

2024-7-25

Intercostal nerve electrodiagnostic testing in rib fractures

2024-7-24

Phantom radiculopathy: An electrodiagnostic challenge

2024-7-24

Evaluation of the applicability of weak shoulder and arm sparing signs in amyotrophic lateral sclerosis by multiple neurologists and neurology residents: A single‐center study

2024-7-24

Structural changes and contractility in muscle assessed by magnetic resonance imaging in individuals with ryanodine receptor 1‐related rhabdomyolysis or myalgia

2024-7-24